A LARGE PRECISION MEDICINE CANCER INITIATIVE TO TEST THE EFFECTIVENESS OF TREATING ADULTS AND CHILDREN WITH NEW DRUG COMBINATIONS THAT TARGET SPECIFIC CANCEROUS TUMOR ALTERATIONS HAS LAUNCHED. KNOWN AS THE COMBINATION THERAPY PLATFORM TRIAL WITH MOLECULAR ANALYSIS FOR THERAPY CHOICE – OR ComboMATCH FOR SHORT -- THE INITIATIVE IS THE LARGEST OF ITS KIND TO TEST COMBINATIONS OF CANCER DRUGS GUIDED BY TUMOR BIOLOGY. DR. JEFFREY MOSCOW IN THE N-C-I’S DIVISION OF CANCER TREATMENT AND DIAGNOSIS SAYS THAT THE ENDEAVOR AIMS TO IDENTIFY PROMISING TREATMENTS THAT CAN ADVANCE TO LARGER, MORE DEFINITIVE CLINICAL TRIALS OUTSIDE OF COMBOMATCH.
Read MoreMuch progress has been made in treating people with melanoma that has spread in their bodies (metastatic melanoma). Yet many people still don't benefit from the newest drugs, and others may relapse after initially successful treatment. In this blog we will cover treatments and research being done in melanoma and other skin cancers.
Read MoreImmunotherapy is a type of cancer treatment that uses substances made by the body or in a laboratory to boost the immune system and help the body find and destroy cancer cells. Immunotherapy can treat many different types of cancer and can be used alone or in combination with chemotherapy and/or other cancer treatments.
Read More